SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12084593
Source:
http://linkedlifedata.com/resource/pubmed/id/12084593
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0078058
,
umls-concept:C0286651
,
umls-concept:C0547047
,
umls-concept:C1171892
,
umls-concept:C1956346
pubmed:issue
12
pubmed:dateCreated
2002-6-26
pubmed:abstractText
The aim of this study was to test a possible influence of atorvastatin on the production of vascular endothelial growth factor (VEGF) in patients with coronary artery disease (CAD) and in vitro.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL
,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids
,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0735-1097
pubmed:author
pubmed-author:AlberHannes FranzHF
,
pubmed-author:DichtlWolfgangW
,
pubmed-author:DulakJozefJ
,
pubmed-author:FrickMatthiasM
,
pubmed-author:PachingerOtmarO
,
pubmed-author:SchwarzacherSeverin PaulSP
,
pubmed-author:WeidingerFranzF
pubmed:issnType
Print
pubmed:day
19
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1951-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12084593-Anticholesteremic Agents
,
pubmed-meshheading:12084593-Cholesterol
,
pubmed-meshheading:12084593-Cholesterol, LDL
,
pubmed-meshheading:12084593-Coronary Disease
,
pubmed-meshheading:12084593-Endothelial Growth Factors
,
pubmed-meshheading:12084593-Heptanoic Acids
,
pubmed-meshheading:12084593-Humans
,
pubmed-meshheading:12084593-Lymphokines
,
pubmed-meshheading:12084593-Male
,
pubmed-meshheading:12084593-Middle Aged
,
pubmed-meshheading:12084593-Pyrroles
,
pubmed-meshheading:12084593-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:12084593-Vascular Endothelial Growth Factors
pubmed:year
2002
pubmed:articleTitle
Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease.
pubmed:affiliation
Division of Cardiology, Department of Internal Medicine, University of Innsbruck, Innsbruck, Austria.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't